At the cellular level, in vitro studies have confirmed that NOX5 promotes proliferation and survival and reduced apoptosis in prostate carcinoma cancer cells, breast cancer cells, lymphoma, Barrett esophageal adenocarcinoma cells, and melanoma [7, 19, 33, 34, 51]. Here, NOX5 is linked to melanoma.